These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39331676)

  • 1. Simulation of cardiac arrhythmias in human induced pluripotent stem cell-derived cardiomyocytes.
    Bommer T; Knierim M; Unsöld J; Riedl D; Stengel L; Paulus M; Körtl T; Liaw N; Maier LS; Streckfuss-Bömeke K; Sossalla S; Pabel S
    PLoS One; 2024; 19(9):e0310463. PubMed ID: 39331676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Kobayashi H; Tohyama S; Ichimura H; Ohashi N; Chino S; Soma Y; Tani H; Tanaka Y; Yang X; Shiba N; Kadota S; Haga K; Moriwaki T; Morita-Umei Y; Umei TC; Sekine O; Kishino Y; Kanazawa H; Kawagishi H; Yamada M; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
    Circulation; 2024 Aug; 150(8):611-621. PubMed ID: 38666382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
    Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
    SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.
    Navarrete EG; Liang P; Lan F; Sanchez-Freire V; Simmons C; Gong T; Sharma A; Burridge PW; Patlolla B; Lee AS; Wu H; Beygui RE; Wu SM; Robbins RC; Bers DM; Wu JC
    Circulation; 2013 Sep; 128(11 Suppl 1):S3-13. PubMed ID: 24030418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?
    Knollmann BC
    Circ Res; 2013 Mar; 112(6):969-76; discussion 976. PubMed ID: 23569106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes.
    Schmid C; Abi-Gerges N; Leitner MG; Zellner D; Rast G
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies.
    Shaheen N; Shiti A; Huber I; Shinnawi R; Arbel G; Gepstein A; Setter N; Goldfracht I; Gruber A; Chorna SV; Gepstein L
    Stem Cell Reports; 2018 Jun; 10(6):1879-1894. PubMed ID: 29754959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response caused by M1 macrophages elicits atrial fibrillation-like phenotypes in coculture model with isogenic hiPSC-derived cardiomyocytes.
    Hutschalik T; Özgül O; Casini M; Szabó B; Peyronnet R; Bártulos Ó; Argenziano M; Schotten U; Matsa E
    Stem Cell Res Ther; 2024 Sep; 15(1):280. PubMed ID: 39227896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.
    da Rocha AM; Campbell K; Mironov S; Jiang J; Mundada L; Guerrero-Serna G; Jalife J; Herron TJ
    Sci Rep; 2017 Oct; 7(1):13834. PubMed ID: 29061979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
    Prajapati C; Ojala M; Aalto-Setälä K
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.
    Song L; Awari DW; Han EY; Uche-Anya E; Park SH; Yabe YA; Chung WK; Yazawa M
    Stem Cells Transl Med; 2015 May; 4(5):468-75. PubMed ID: 25769651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases.
    Pourrier M; Fedida D
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating inherited arrhythmias using hiPSC-derived cardiomyocytes.
    Arslanova A; Shafaattalab S; Lin E; Barszczewski T; Hove-Madsen L; Tibbits GF
    Methods; 2022 Jul; 203():542-557. PubMed ID: 34197925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.
    Sinnecker D; Goedel A; Laugwitz KL; Moretti A
    Circ Res; 2013 Mar; 112(6):961-8. PubMed ID: 23569105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
    Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
    Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.
    Li M; Kanda Y; Ashihara T; Sasano T; Nakai Y; Kodama M; Hayashi E; Sekino Y; Furukawa T; Kurokawa J
    J Pharmacol Sci; 2017 Jun; 134(2):75-85. PubMed ID: 28615142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.